Methohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
QuVa Pharma is recalling Methohexital Sodium 100 mg/10 mL compounded drug vials due to failed impurities and degradation specifications. The recall affects multiple lot numbers distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text specifies only failed impurities and degradation specifications with no reported illnesses or injuries, which qualifies as a moderate-severity precautionary recall.
Plain-English summary
QuVa Pharma, Inc. is recalling Methohexital Sodium 100 mg/10 mL (10 mg/mL), Rx only, a compounded drug product due to failed impurities and degradation specifications. The affected product is distributed nationwide within the United States.
The recall affects multiple lot numbers with expiration dates ranging from July 2026 through August 2026, including lots 10162261, 10162262, 10162279, 10162280, 10162314, 10162315, 10162465, 10162466, 10162491, 10162492, 10162542, 10162543, 10162559, 10162560, 10162623, 10162624, 10162693, 10162694, 10162735, 10162736, 10162753, 10162754, 10162772, 10162773, 10162791, 10162792, 10162810, 10162811, 10162820, 10162853, 10162854, 10163046, 10163156, and 10163157. The product code is 70092-1310-46.
Consumers and healthcare providers should discontinue use of the affected lots. For questions or additional information, contact QuVa Pharma, Inc. at 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478.
The recalled product
- Product
- Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46.
- Manufacturer
- QuVa Pharma, Inc.
- Category
- Drug — Compounded Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 10162261
- 10162262
- 10162279
- 10162280
- Exp. Date 07/21/2026
- 10162314
- 10162315
- Exp. Date 07/22/2026
- 10162465
- 10162466
- 10162491
- 10162492
- Exp. Date 07/26/2026
- 10162542
- 10162543
- Exp. Date 07/27/2026
- 10162559
- 10162560
- Exp. Date 07/28/2026
- 10162623
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · QuVa Pharma, Inc.
See all →- HighCompounded pain injection syringes recalled over presence of particulate matter
FDA (Drugs) · 2025-11-05
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Bupivacaine Epidural Injections Recalled for Sterility Failure
FDA (Drugs) · 2025-04-02
- HighCompounded Fentanyl-Ropivacaine Epidural Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2025-04-02
- HighOxytocin injection recalled for incorrect sodium chloride concentration
FDA (Drugs) · 2022-10-05
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24